{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.11.1527",
  "meta" : {
    "versionId" : "16",
    "lastUpdated" : "2021-02-20T01:03:49.000-05:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1527",
  "version" : "20210220",
  "name" : "Scopolamine",
  "status" : "active",
  "date" : "2021-02-20T01:03:49-05:00",
  "publisher" : "NCQA PHEMUR",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "concept" : [{
        "code" : "1046787",
        "display" : "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
      },
      {
        "code" : "1046815",
        "display" : "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
      },
      {
        "code" : "1046997",
        "display" : "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
      },
      {
        "code" : "1048124",
        "display" : "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
      },
      {
        "code" : "1048147",
        "display" : "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.3111 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
      },
      {
        "code" : "198207",
        "display" : "scopolamine 0.4 MG/ML Injectable Solution"
      },
      {
        "code" : "226552",
        "display" : "72 HR scopolamine 0.0139 MG/HR Transdermal System"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:d34fcc78-efc4-469b-bb7a-0c850b01dfff",
    "timestamp" : "2022-09-28T01:13:45-04:00",
    "total" : 6,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "1046787",
      "display" : "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "1046815",
      "display" : "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "1046997",
      "display" : "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "1048124",
      "display" : "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "198207",
      "display" : "scopolamine 0.4 MG/ML Injectable Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "226552",
      "display" : "72 HR scopolamine 0.0139 MG/HR Transdermal System"
    }]
  }
}